202 related articles for article (PubMed ID: 33212461)
1. Depression Disorders in Patients with Chronic Hepatitis C.
Bebek-Ivankovic H; Bevanda M; Susak B; Grgic S; Soldo-Coric L; Nikolic J
Psychiatr Danub; 2020 Nov; 32(Suppl 4):540-546. PubMed ID: 33212461
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.
Banjac V; Zivlak-Radulovic N; Miskovic M
Med Arch; 2016 Apr; 70(2):127-30. PubMed ID: 27147788
[TBL] [Abstract][Full Text] [Related]
3. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Schaefer M; Hinzpeter A; Mohmand A; Janssen G; Pich M; Schwaiger M; Sarkar R; Friebe A; Heinz A; Kluschke M; Ziemer M; Gutsche J; Weich V; Halangk J; Berg T
Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Schaefer M; Mauss S
Curr Drug Abuse Rev; 2008 Jun; 1(2):177-87. PubMed ID: 19630716
[TBL] [Abstract][Full Text] [Related]
6. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Wang LJ; Chen SW; Chen CK; Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chien RN
BMC Psychiatry; 2016 Nov; 16(1):424. PubMed ID: 27884134
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
[TBL] [Abstract][Full Text] [Related]
8. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
Vabo IL; Ferreira LE; Pace FH
Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
[TBL] [Abstract][Full Text] [Related]
9. Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance.
Dimitroulopoulos D; Petroulaki E; Manolakopoulos S; Anagnostou O; Tsaklakidou D; Xinopoulos D; Tsamakidis K; Tzourmakliotis D; Paraskevas E
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1407-12. PubMed ID: 19916203
[TBL] [Abstract][Full Text] [Related]
10. Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.
Fontana RJ; Schwartz SM; Gebremariam A; Lok AS; Moyer CA
Psychosomatics; 2002; 43(5):378-85. PubMed ID: 12297606
[TBL] [Abstract][Full Text] [Related]
11. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
12. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
Halász T; Farkas A; Tolvaj G; Horváth G
Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
[TBL] [Abstract][Full Text] [Related]
13. Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.
Belfiori B; Ciliegi P; Chiodera A; Bacosi D; Tosti A; Baldelli F; Francisci D
Dig Liver Dis; 2009 Apr; 41(4):303-7. PubMed ID: 18938116
[TBL] [Abstract][Full Text] [Related]
14. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.
Gleason OC; Fucci JC; Yates WR; Philipsen MA
Dig Dis Sci; 2007 Oct; 52(10):2557-63. PubMed ID: 17436092
[TBL] [Abstract][Full Text] [Related]
15. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
Hunyady B; Kovács B; Battyáni Z
Orv Hetil; 2011 Dec; 152(50):1997-2009. PubMed ID: 22112373
[TBL] [Abstract][Full Text] [Related]
16. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
Małyszczak K; Inglot M; Frydecka D; Hadryś T; Pawłowski T
Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.
Evon DM; Ramcharran D; Belle SH; Terrault NA; Fontana RJ; Fried MW;
Am J Gastroenterol; 2009 Dec; 104(12):2949-58. PubMed ID: 19789525
[TBL] [Abstract][Full Text] [Related]
18. De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.
Martín-Santos R; Díez-Quevedo C; Castellví P; Navinés R; Miquel M; Masnou H; Soler A; Ardevol M; García F; Galeras JA; Planas R; Solà R
Aliment Pharmacol Ther; 2008 Feb; 27(3):257-65. PubMed ID: 17988237
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
Krook AL; Stokka D; Heger B; Nygaard E
Eur Addict Res; 2007; 13(4):216-21. PubMed ID: 17851243
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
Kraus MR; Schäfer A; Al-Taie O; Scheurlen M
J Viral Hepat; 2005 Jan; 12(1):96-100. PubMed ID: 15655055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
